| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.00098 | 1 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.0009 | 1 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.00068 | 1 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.0007 | 1 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.00067 | 1 |